<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00166192</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00024850</org_study_id>
    <nct_id>NCT00166192</nct_id>
  </id_info>
  <brief_title>Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid</brief_title>
  <official_title>Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Melasma is an acquired discoloration of the skin characterized by brown patches. Chemical
      peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly
      used to treat melasma. A chemical peel involves applying the peeling agent to the skin for a
      short period. The skin will peel similar to a sunburn, and moisturizers are applied to the
      skin. Although both agents are well-accepted, there have been no good comparisons of the two
      agents. The purpose of this study is determine if there is a difference in the effectiveness
      of these two agents.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical efficacy by clinician's evaluation</measure>
    <time_frame>3 months</time_frame>
    <description>Hyperpigmenation Global Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy by subject's evaluation</measure>
    <time_frame>3 months</time_frame>
    <description>Hyperpigmentation Global Score</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Melasma</condition>
  <arm_group>
    <arm_group_label>Chemical Peel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Split face treatment paradigm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Jessner's solution chemical peel</intervention_name>
    <arm_group_label>Chemical Peel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trichloroacetic acid chemical peel</intervention_name>
    <arm_group_label>Chemical Peel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults &gt; 18 years old

          -  Clinical diagnosis of melasma

          -  Mental capacity to give informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  H/o allergy to Jessner's solution, tricholoracetetic acid, tretinoin, or hydroquinone

          -  Active dermatitis

          -  Presence of cutaneous infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl Washington, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University Department of Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University Dermatology Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>November 12, 2013</last_update_submitted>
  <last_update_submitted_qc>November 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Zakiya Rice</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Melasma</keyword>
  <keyword>Jessner's solution</keyword>
  <keyword>Trichloroacetic acid (TCA)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Salicylates</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

